AngioDynamics Property Plant And Equipment Gross vs Total Current Assets Analysis
ANGO Stock | USD 6.31 0.04 0.64% |
AngioDynamics financial indicator trend analysis is way more than just evaluating AngioDynamics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AngioDynamics is a good investment. Please check the relationship between AngioDynamics Property Plant And Equipment Gross and its Total Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Property Plant And Equipment Gross vs Total Current Assets
Property Plant And Equipment Gross vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AngioDynamics Property Plant And Equipment Gross account and Total Current Assets. At this time, the significance of the direction appears to have almost no relationship.
The correlation between AngioDynamics' Property Plant And Equipment Gross and Total Current Assets is 0.12. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of AngioDynamics, assuming nothing else is changed. The correlation between historical values of AngioDynamics' Property Plant And Equipment Gross and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of AngioDynamics are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Property Plant And Equipment Gross i.e., AngioDynamics' Property Plant And Equipment Gross and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.12 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Property Plant And Equipment Gross
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Discontinued Operations is very stable compared to the past year. As of the 3rd of June 2024, Enterprise Value is likely to grow to about 352.9 M, while Selling General Administrative is likely to drop about 27.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 165.7M | 174.2M | 200.4M | 129.6M | Total Revenue | 316.2M | 338.8M | 389.6M | 242.9M |
AngioDynamics fundamental ratios Correlations
Click cells to compare fundamentals
AngioDynamics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AngioDynamics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 38.0M | 38.3M | 39.0M | 39.5M | 45.4M | 29.4M | |
Total Assets | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Short Long Term Debt Total | 40.8M | 20M | 33.8M | 49.8M | 57.3M | 66.3M | |
Other Current Liab | 2.1M | 38.0M | 21.5M | 43.4M | 49.9M | 52.4M | |
Total Current Liabilities | 51.5M | 57.6M | 74.3M | 83.8M | 96.4M | 48.7M | |
Total Stockholder Equity | 455.9M | 439.5M | 424.5M | 378.3M | 435.0M | 404.2M | |
Property Plant And Equipment Net | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 35.0M | |
Net Debt | (13.6M) | (28.2M) | 5.0M | 5.2M | 6.0M | 5.7M | |
Retained Earnings | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Accounts Payable | 19.1M | 19.6M | 28.0M | 40.4M | 46.5M | 48.8M | |
Cash | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 45.7M | |
Non Current Assets Total | 442.6M | 420.6M | 409.4M | 369.1M | 424.5M | 382.2M | |
Other Assets | 5.2M | 3.8M | 11.0M | 49.2M | 56.6M | 59.4M | |
Long Term Debt | 40M | 20M | 25M | 49.8M | 57.3M | 58.7M | |
Cash And Short Term Investments | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 61.7M | |
Net Receivables | 31.3M | 35.4M | 52.3M | 52.8M | 60.7M | 38.3M | |
Common Stock Total Equity | 374K | 377K | 380K | 382K | 439.3K | 308.9K | |
Liabilities And Stockholders Equity | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Non Current Liabilities Total | 88.1M | 64.4M | 53.9M | 70.5M | 81.1M | 80.5M | |
Inventory | 59.9M | 48.6M | 51.4M | 55.3M | 63.6M | 42.5M | |
Other Current Assets | 2.2M | 1.8M | 2.2M | 4.6M | 4.2M | 4.5M | |
Other Stockholder Equity | 557.2M | 567.8M | 581.2M | 593.5M | 682.5M | 424.4M | |
Total Liab | 139.6M | 122.0M | 128.3M | 154.3M | 177.5M | 129.1M | |
Property Plant And Equipment Gross | 28.3M | 37.1M | 96.1M | 44.4M | 51.0M | 37.5M | |
Total Current Assets | 152.9M | 140.9M | 143.3M | 163.5M | 188.1M | 151.2M | |
Accumulated Other Comprehensive Income | (1.3M) | 3.2M | 1.4M | (4.7M) | (5.4M) | (5.2M) | |
Short Term Debt | 836K | 2.4M | 8.8M | 14.8M | 17.0M | 8.5M | |
Intangible Assets | 197.1M | 169.0M | 152.4M | 111.1M | 127.8M | 113.3M | |
Common Stock | 374K | 377K | 380K | 382K | 439.3K | 309.7K | |
Property Plant Equipment | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 34.9M | |
Non Currrent Assets Other | 15.6M | 13.2M | (5.1M) | 54.3M | 62.5M | 65.6M | |
Other Liab | 39.6M | 37.1M | 24.2M | 17.4M | 20.0M | 32.6M | |
Good Will | 201.5M | 201.3M | 201.1M | 159.2M | 183.1M | 283.9M | |
Net Tangible Assets | 57.2M | 69.2M | 71.1M | 378.3M | 435.0M | 456.8M | |
Retained Earnings Total Equity | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Long Term Debt Total | 40M | 20M | 25M | 49.8M | 44.8M | 69.2M | |
Capital Surpluse | 561.9M | 573.5M | 586.9M | 599.2M | 689.1M | 600.4M | |
Deferred Long Term Liab | 24.1M | 20.0M | 16.0M | 12.8M | 14.7M | 14.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 8.105 | Quarterly Revenue Growth (0.07) | Return On Assets (0.05) | Return On Equity (0.62) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.